Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1861 AL 1875

[Cognition in Down's Syndrome: Development across the Life Span and Neuropsychological Assessment in Adults]

Loosli SV, Schmidt L, Nübling G, Wlasich E, Prix C, Danek A, Levin J.

Fortschr Neurol Psychiatr. 2021 Sep;89(9):433-444. doi: 10.1055/a-1362-9868. Epub 2021 Mar 1.

PET imaging of neural activity, β-amyloid, and tau in normal brain aging

Zhang K, Mizuma H, Zhang X, Takahashi K, Jin C, Song F, Gao Y, Kanayama Y, Wu Y, Li Y, Ma L, Tian M, Zhang H, Watanabe Y.

Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3859-3871. doi: 10.1007/s00259-021-05230-5. Epub 2021 Mar 5.

Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET

Devous MD Sr, Fleisher AS, Pontecorvo MJ, Lu M, Siderowf A, Navitsky M, Kennedy I, Southekal S, Harris TS, Mintun MA.

J Alzheimers Dis. 2021;80(3):1091-1104. doi: 10.3233/JAD-200808.

Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from (18)F-FDG PET brain persistent homology network

Hsu TW, Fuh JL, Wang DW, Chen LF, Chang CJ, Huang WS, Wu HM, Guo WY.

Sci Rep. 2021 Mar 8;11(1):5396. doi: 10.1038/s41598-021-84722-8.

The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow

Beishon LC, Panerai RB, Budgeon C, Subramaniam H, Mukaetova-Ladinska E, Robinson TG, Haunton VJ.

J Alzheimers Dis. 2021;80(4):1567-1581. doi: 10.3233/JAD-201444.

Functional autonomy in dementia of the Alzheimer's type, mild cognitive impairment, and healthy aging: a meta-analysis

Altieri M, Garramone F, Santangelo G.

Neurol Sci. 2021 May;42(5):1773-1783. doi: 10.1007/s10072-021-05142-0. Epub 2021 Mar 18.

Cerebral blood flow changes during aging process and in cognitive disorders: A review

Mokhber N, Shariatzadeh A, Avan A, Saber H, Babaei GS, Chaimowitz G, Azarpazhooh MR.

Neuroradiol J. 2021 Aug;34(4):300-307. doi: 10.1177/19714009211002778. Epub 2021 Mar 22.

Incidence and risk factors of dementia and the primary subtypes in northern rural China

Gu X, Shi Z, Liu S, Guan Y, Lu H, Zhang Y, Zhang M, Liu S, Yue W, Wu H, Wang X, Zhang Y, Ji Y.

Medicine (Baltimore). 2021 Apr 2;100(13):e25343. doi: 10.1097/MD.0000000000025343.

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals

Ng KP, Chiew H, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S.

Transl Neurodegener. 2021 Mar 31;10(1):11. doi: 10.1186/s40035-021-00236-3.

The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations

Wales RM, Leung HC.

Brain Connect. 2021 Oct;11(8):599-612. doi: 10.1089/brain.2020.0902. Epub 2021 May 17.

Visit-to-Visit Blood Pressure Variability and Incident Frailty in Older Adults

Rouch L, De Souto Barreto P, Hanon O, Vidal JS, Amar J, Andrieu S, Cestac P, Rolland Y, Vellas B; MAPT/DSA Group.

J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1369-1375. doi: 10.1093/gerona/glab112.

Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional

Vipin A, Wong BYX, Kumar D, Low A, Ng KP, Kandiah N.

Aging (Albany NY). 2021 Apr 16;13(8):10973-10988. doi: 10.18632/aging.202977. Epub 2021 Apr 16.

Repetition Priming in Individuals with Amnestic Mild Cognitive Impairment and Alzheimer's Dementia: a Systematic Review and Meta-Analysis

De Wit L, Piai V, Thangwaritorn P, Johnson B, O'Shea D, Amofa P Sr, Marsiske M, Kessels RPC, Schaefer N, Smith G.

Neuropsychol Rev. 2022 Jun;32(2):228-246. doi: 10.1007/s11065-021-09504-5. Epub 2021 Apr 25.

[Research on the application of convolution neural network in the diagnosis of Alzheimer's disease]

Xu B, Ding C, Xu G.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2021 Feb 25;38(1):169-177. doi: 10.7507/1001-5515.202007019.

Development of novel measures for Alzheimer's disease prevention trials (NoMAD)

Bell SA, Cohen HR, Lee S, Kim H, Ciarleglio A, Andrews H, Rivera AM, Igwe K, Brickman AM, Devanand DP, Harvey PD, Schneider LS, Goldberg TE.

Contemp Clin Trials. 2021 Jul;106:106425. doi: 10.1016/j.cct.2021.106425. Epub 2021 Apr 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias